Compare Mutual Funds

Pros
Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons
3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

-

INDMoney rank
6/8
1/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 3 Months

7 Years 8 Months

Fund AUM

₹7875 Cr

₹6658 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.92%

1.02%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

39

42

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.02%)
  2. Lupin Ltd(7.36%)
  3. Divi's Laboratories Ltd(6.58%)
  4. Cipla Ltd(6.39%)
  5. Dr Reddy's Laboratories Ltd(6.02%)
  1. Sun Pharmaceuticals Industries Ltd(12.05%)
  2. Cipla Ltd(7.9%)
  3. Dr Reddy's Laboratories Ltd(7.82%)
  4. Divi's Laboratories Ltd(7.1%)
  5. Mankind Pharma Ltd(6.44%)
No of Sectors

1

2

Top 3 Sectors

Health

(100%)

  1. Health(98.89%)
  2. Basic Materials(1.11%)
Equity %

97.37%

97.87%

Debt %

-

-

P/E

34.75

31.1

P/B

5.37

3.84

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-0.97%

-3.58%

3-Month Return

-2.66%

-6.72%

6-Month Return

-2.59%

-5.58%

1-Year Return

6.75%

4.81%

3-Year Return

23.43%

27.26%

5-Year Return

15.68%

17.45%

Sharpe

0.97

1.19

Alpha

0.33

3.82

Beta

0.9

0.95

Standard Deviation

15.32

16.02

Information Ratio

-0.32

1.23

Description

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sailesh Raj Bhan, Lokesh Maru, Kinjal Desai, Divya Sharma

Dharmesh Kakkad, Sharmila D’mello

Most Popular Comparisons